Adrenergic regulation of the rapid component of the cardiac delayed rectifier potassium current, I(Kr), and the underlying hERG ion channel

Basic Research in Cardiology
Dierk ThomasChristoph A Karle

Abstract

Ventricular arrhythmias are often precipitated by physical or emotional stress, in particular in patients with ischemic heart disease or hereditary long QT syndrome. Stimulation of the sympathetic nervous system in response to exercise or emotional stress causes activation of cardiac alpha- and beta-adrenoceptors. The rapid component of the delayed rectifier potassium current, I(Kr), and the underlying hERG potassium channel are critical for the regulation of heart rhythm. Recent experimental studies revealed that hERG/I(Kr) currents are modulated by alpha- and beta-adrenergic stimulation, providing a pathophysiological explanation for the increased incidence of arrhythmias during stress. This review summarizes the current knowledge on hERG/I(Kr) channel modulation by adrenergic activity. In addition, therapeutic approaches to future effective, more genotype-specific antiarrhythmic therapies are discussed.

Citations

Sep 15, 2004·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Dierk ThomasChristoph A Karle
Dec 2, 2010·Naunyn-Schmiedeberg's Archives of Pharmacology·Ingo StaudacherDierk Thomas
Jul 25, 2007·The Lancet Infectious Diseases·Nicholas J White
Mar 2, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Christina U LorentzBeth A Habecker
Nov 13, 2008·Pflügers Archiv : European journal of physiology·Carlos Alonso-RonPilar de la Peña
Mar 15, 2012·Pflügers Archiv : European journal of physiology·Luis CarreteroPedro Domínguez
Feb 19, 2014·Pflügers Archiv : European journal of physiology·Tamas BanyaszYe Chen-Izu
Oct 28, 2009·Cellular and Molecular Life Sciences : CMLS·Cia RamströmKid Törnquist
Dec 18, 2007·Journal of Cardiovascular Electrophysiology·Gianfranco PiccirilloVincenzo Marigliano
Dec 18, 2007·Journal of Cardiovascular Electrophysiology·Olivier XhaëtPhilippe Van de Borne
Jun 25, 2010·British Journal of Clinical Pharmacology·Michael E O'Leary, Jules C Hancox
Nov 18, 2005·Journal of Pharmacological and Toxicological Methods·Peter Hoffmann, Barbara Warner
Apr 10, 2016·The Journal of Physiology·Beth A HabeckerCrystal M Ripplinger
Apr 5, 2011·Biochemical and Biophysical Research Communications·Benjamin MederWolfgang Rottbauer
Nov 4, 2016·The Journal of Physiology·Nipavan ChiamvimonvatJeanne M Nerbonne
Mar 10, 2016·Biophysical Journal·Maura M Zylla, Dierk Thomas
Sep 1, 2006·Resuscitation·Li Xiong LuChangqing Zhu
May 20, 2017·Journal of Applied Physiology·Xinrui Wang, Robert H Fitts
Jan 27, 2016·Circulation. Arrhythmia and Electrophysiology·Ryan T GardnerBeth A Habecker
May 26, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xun WangAmber L Pond
Oct 2, 2019·Expert Opinion on Drug Discovery·Alexander PottSteffen Just
Jan 20, 2017·Experimental and Therapeutic Medicine·Mingyu FuXinjiang An

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.